MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
83 hedge funds and large institutions have $280M invested in Marinus Pharmaceuticals, Inc in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
12% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 25
21% less capital invested
Capital invested by funds: $355M → $280M (-$75.1M)
Holders
83
Holding in Top 10
2
Calls
$4.11M
Puts
$2.85M
Top Buyers
| 1 | +$2.59M | |
| 2 | +$2.43M | |
| 3 | +$2.28M | |
| 4 |
AC
Antara Capital
New York
|
+$1.78M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$1.19M |
Top Sellers
| 1 | -$3.65M | |
| 2 | -$2.04M | |
| 3 | -$1.84M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$1.54M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1M |